Lifestyle
- Reduce alcohol intake
- Maintain a healthy weight
- Exercise regularly
Gamma-Glutamyltransferase · Gamma-GT · GGT
GGT quantifies the enzyme gamma-glutamyltransferase, which is involved in glutathione metabolism.
Reference ranges may vary slightly based on laboratory standards. Men typically have higher GGT levels than women.
Gamma-glutamyltransferase (GGT) is an enzyme that plays a crucial role in the metabolism of glutathione, a major antioxidant in the body. It is primarily found in the liver but is also present in other tissues such as the kidney and pancreas. GGT is involved in the transfer of gamma-glutamyl functional groups, which is essential for the breakdown and utilization of glutathione. Clinically, GGT is a significant biomarker for liver function and is often used to detect liver diseases, including alcoholic liver disease, biliary obstruction, and non-alcoholic fatty liver disease. Elevated GGT levels can indicate liver damage or dysfunction, and it is commonly used alongside other liver enzymes like ALT and AST to assess liver health. In the context of athletic performance and biohacking, GGT may be relevant as it reflects oxidative stress and liver health, which are critical for recovery and overall metabolic function. High GGT levels have been associated with increased mortality and frailty in older adults, suggesting its potential role in longevity studies. However, several factors can confound GGT levels, including alcohol consumption, obesity, and certain medications. Time of day and fasting status do not significantly affect GGT measurements, but recent alcohol intake can elevate levels. Researchers recommend considering these factors when interpreting GGT results to avoid misdiagnosis or overestimation of liver dysfunction.
Klinische Bedeutung
Elevated GGT levels indicate potential liver damage or dysfunction, often associated with alcohol use, liver disease, or bile duct issues. Low GGT levels are generally not clinically significant.
Progressively rising GGT values suggest worsening liver function or increased oxidative stress. Re-test in 4 weeks if elevated.
Falling GGT values indicate improvement in liver function or reduced oxidative stress.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before making significant lifestyle changes, especially if liver disease is suspected.
GGT levels may vary with diurnal rhythms; consistency in testing time is recommended.
Testing Frequency
Annually for adults with risk factors for liver disease
Correlated with
Current research suggests that reference intervals for GGT may need reevaluation, particularly concerning confounding factors like gender, age, and lifestyle. Researchers have not yet established optimal GGT targets for predicting outcomes in various populations, such as those with cardiac amyloidosis or frailty. Additionally, clinical questions remain unanswered regarding the causal relationship between elevated GGT levels and the progression of frailty or other age-related conditions.
1,090
Total Citations
10
Human/RCT
4.9
Avg. Influence
2018
Latest
Researchers found that elevated gamma-glutamyltransferase (GGT) levels are linked to increased risks of various diseases, including cardiovascular disease and diabetes. The study suggests that GGT could serve as a predictive biomarker for multiple health conditions beyond liver disease.
Researchers found that serum gamma-glutamyltransferase (GGT) is a valuable biomarker for diagnosing alcohol use disorders. The study suggests that combining GGT with carbohydrate-deficient transferrin (CDT) improves diagnostic sensitivity without losing specificity. Additionally, the research highlights the need to reassess reference intervals for ethanol-sensitive biomarkers.
Researchers reviewed various biomarkers of alcohol consumption, including gamma-glutamyltransferase (GGT), highlighting their importance in clinical and forensic contexts. The study emphasized the role of GGT in verifying abstinence and detecting harmful alcohol use, suggesting a combination of markers for accurate assessment.
Researchers highlighted that gamma-glutamyltransferase (GGT) may have pathogenic effects beyond its role as an antioxidant enzyme. The study reviews its involvement in various diseases, including cardiovascular conditions and cancer, suggesting a complex role in human health.
Researchers found that gamma-glutamyltransferase (GGT) levels may indicate cardiovascular risk, linking oxidative stress to atherogenesis. The study suggests that GGT could be a useful biomarker for identifying individuals at risk for cardiovascular events.
This systematic review assessed the prognostic role of serum gamma-glutamyltransferase (GGT) in patients with genitourinary cancers. Researchers found that elevated GGT levels are associated with an increased risk of cancer progression and poor prognosis, highlighting its potential as a biomarker for monitoring these patients.
Researchers found that gamma-glutamyltransferase (GGT) levels in horses can indicate liver disease, particularly biliary necrosis or hyperplasia. The study classified liver enzymes into hepatocellular and cholestatic groups, with GGT being a key marker for acute liver conditions. Changes in GGT levels can help differentiate between types of liver pathologies.
Researchers examined the association between gamma-glutamyltransferase (GGT) levels and body fat distribution in healthy individuals. They found that increased GGT was linked to higher android fat and a higher android/gynoid fat ratio, indicating its potential as an early biomarker for unfavorable body fat distribution.
This clinical study examined the relationship between gamma-glutamyltransferase (GGT) levels and COVID-19 in hospitalized patients. Researchers found that 32.7% of patients had elevated GGT levels, which were associated with longer hospital stays and other elevated biomarkers. The study suggests liver involvement in COVID-19 cases.
Researchers observed that prolonged administration of lamivudine in rats led to increased levels of gamma-glutamyltransferase (GGT) and other liver enzymes. The study indicated that lamivudine toxicity may be mediated by oxidative stress, highlighting the role of GGT in liver injury.
Research publications about GGT over time
8totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer